When producing a quality vaccine, all manufacturers must confirm the purity as well as the stability of their formulation and final product. Sample quantity and measurement time are often the throughput bottlenecks encountered during the process. As PerkinElmer’s LabChip® GXII Touch™ protein characterization system addresses these specific gaps, we’ve developed a literature-centric webinar. In this webinar you will learn:
- The vaccine development and manufacturing process
- The key applications of microfluidic CE in vaccine process development
Jeray Thelwell, a Mid-Atlantic and Southeast Biotherapeutics Solutions Specialist. A researcher at heart, Jeray is an expert in assay development and automated liquid handling for genomic and biotherapeutic applications.